ENANTA PHARMACEUTICALS, INC Cash and Cash Equivalents, Fair Value Disclosure
ENANTA PHARMACEUTICALS, INC (ENTA) had Cash and Cash Equivalents, Fair Value Disclosure of $12.88 million as of 2017-03-31, per its 10-Q filed 2017-05-10.
Discontinued › Notes › Fair Value Disclosures › Financial Instruments, Financial Assets, Balance Sheet Groupings
us-gaap:CashAndCashEquivalentsFairValueDisclosure · last filed 2017-05-10
- 2017-03-31: Cash and Cash Equivalents, Fair Value Disclosure $12.88M.
- 2016-12-31: Cash and Cash Equivalents, Fair Value Disclosure $17.26M.
- 2016-09-30: Cash and Cash Equivalents, Fair Value Disclosure $15.29M.
- 2016-06-30: Cash and Cash Equivalents, Fair Value Disclosure $20.53M.
| Period end | Cash and Cash Equivalents, Fair Value Disclosure |
|---|---|
| 2017-03-31 | $12.88M 10-Q · filed 2017-05-10 |
| 2016-12-31 | $17.26M 10-Q · filed 2017-02-09 |
| 2016-09-30 | $15.29M 10-Q · filed 2017-05-10 |
| 2016-06-30 | $20.53M 10-Q · filed 2016-08-09 |
| 2016-03-31 | $52.73M 10-Q · filed 2016-05-10 |
| 2015-12-31 | $40.46M 10-Q · filed 2016-02-09 |
| 2015-09-30 | $21.33M 10-K · filed 2016-12-09 |
| 2014-09-30 | $30.24M 10-K · filed 2015-12-11 |
| 2014-06-30 | $21.97M 10-Q · filed 2014-08-12 |
| 2014-03-31 | $15.28M 10-Q · filed 2014-05-12 |
| 2013-12-31 | $2.28M 10-Q · filed 2014-02-13 |
| 2013-09-30 | $7.52M 10-K · filed 2014-12-11 |
| 2013-06-30 | $16.98M 10-Q · filed 2013-08-12 |
| 2013-03-31 | $72.02M 10-Q · filed 2013-05-15 |
| 2012-09-30 | $6.47M 10-K · filed 2013-12-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Emergent BioSolutions Inc. (EBS) | United States | $0.347B | -2.43 |
| Larimar Therapeutics, Inc. (LRMR) | United States | $0.344B | -1.83 |
| Vogenx, Inc. (VOGX) | United States | $0.355B | |
| Benitec Biopharma Inc. (BNTC) | United States | $0.337B | -10.08 |
| BioAge Labs, Inc. (BIOA) | United States | $0.333B | -11.88 |
| BridgeBio Oncology Therapeutics, Inc. (BBOT) | United States | $0.320B | -3.35 |
| Evommune, Inc. (EVMN) | United States | $0.320B | -5.10 |
| Prelude Therapeutics Inc (PRLD) | United States | $0.318B | -7.01 |
| Rezolute, Inc. (RZLT) | United States | $0.382B | -6.45 |
| ABEONA THERAPEUTICS INC. (ABEO) | United States | $0.312B | -5.63 |